1. Differentiate seizure and epilepsy types inclusive of International League Against Epilepsy (ILAE) classifications that reflect underlying mechanisms
2. Assess etiology of seizures, along with age of onset and risk factors, to anticipate risk of recurrence
3. Integrate genetic testing in the diagnostic assessment for infants with recurrent seizures
4. Evaluate novel treatments for epilepsy syndromes, comparing efficacy data, adverse events (AEs), pharmacokinetic parameters, and clinical practice pearls involved in their use in infants and children
5. Evaluate evidence-based antiepileptic treatment options in children and adults with regard to mechanism of action (MOA), efficacy, pharmacokinetic profiles, drug interactions, and risk of AEs
6. Categorize basic benign and abnormal waveforms to interpret EEGs with review of frequency, amplitude, location, characteristics, and clinical prognosis
7. Identify when refractory patients are candidates for surgery, neurostimulation, or deep brain stimulation based on desired outcomes of these interventions
8. Identify the impact of CT, MRI, fMRI, MRS, MSI, SPECT, and PET findings on epilepsy and other relevant neurological abnormalities as they relate to diagnosis, treatment, and presurgical planning
9. Develop appropriate treatment plans for female patient with epilepsy that consider impact of hormones, pregnancy, and risk for long-term AEs such as osteoporosis
10. Integrate appropriate guidance to a patient and family early in their disease course with regard to prognosis, safety concerns/driving, and treatment decision-making
    
    

Target Audience